Arima Anastasios 4

4 · IPERIONX Ltd · Filed Apr 2, 2026

AI-generated summary of this filing

Updated Apr 2, 2026

IPERIONX CEO Arima Anastasios Receives Share Awards

What Happened

Arima Anastasios, CEO of IPERIONX Ltd (IPX), was granted a package of equity awards on 2026-04-02 totaling 1,441,908 instruments. The filing shows three items: 237,944 shares (price N/A) and two derivative awards priced at A$18.00 (564,759 units, total A$10,165,662) and A$22.00 (639,205 units, total A$14,062,510). These are awards/grants (Form 4 transaction code A) rather than open-market purchases or sales.

Key Details

Transaction date: 2026-04-02 (filing accession: 0001864247-26-000005).
Awards granted: 237,944 (price N/A); 564,759 at A$18.00 (A$10,165,662); 639,205 at A$22.00 (A$14,062,510). Total instruments = 1,441,908.
Shares owned after transaction: not specified in the provided excerpt.
Notable footnotes from the filing:
- F5: amounts/prices are in Australian dollars (A$).
- F1/F3/F4: Ordinary shares trade on the ASX; American Depositary Shares (ADS) trade on Nasdaq; 1 ADS = 10 ordinary shares.
- F6: Performance rights convert 1-for-1 into ordinary shares after meeting (a) four years of continuous service through 04/02/2030 and (b) an ASX 30-day VWAP of A$18.00.
- F7: Options (where applicable) give the right to buy one ordinary share at the stated conversion/exercise price.
- F2: Vesting schedule notes (in the filing) that 318,666 vest in Dec 2026 and 419,910 vest in Apr 2028.
Filing timeliness: the report date and filing date are both 2026-04-02 (no late filing indicated in the provided data).

Context

These are grant/award transactions (derivative awards and share grants), not open-market purchases or sales. Derivative awards (performance rights/options) typically convert to ordinary shares only after vesting and satisfaction of performance conditions (see F6/F7). Awards can be part of long-term incentive compensation and do not by themselves indicate immediate buying or selling in the market.

Form 4

Period: 2026-04-02

DirectorChief Executive Officer

Transactions

Award
Performance Rights (A$18)
[F5][F6][F1]
2026-04-02+237,944→ 237,944 total
Exercise: $18.00From: 2030-04-02Exp: 2031-04-02→ IPX Ordinary Shares (237,944 underlying)
Award
Options (A$18)
[F5][F7][F1]
2026-04-02$18.00/sh+564,759$10,165,662→ 564,759 total
Exercise: $18.00From: 2030-04-02Exp: 2031-04-02→ IPX Ordinary Shares (564,759 underlying)
Award
Options (A$22)
[F5][F7][F1]
2026-04-02$22.00/sh+639,205$14,062,510→ 639,205 total
Exercise: $22.00From: 2030-04-02Exp: 2031-04-02→ IPX Ordinary Shares (639,205 underlying)

Holdings

Ordinary Shares
[F1]
12,206,782
Restricted Stock Units
[F2]
738,576
American Depository Shares (ADS)
[F3][F4][F1]
→ IPX Ordinary Shares (128,000 underlying)
12,800
Performance Rights (A$6)
[F5][F1]
Exercise: $6.00From: 2029-04-10Exp: 2030-04-10→ IPX Ordinary Shares (435,806 underlying)
435,806
Performance Rights (A$7)
[F5][F1]
Exercise: $7.00From: 2029-04-10Exp: 2030-04-10→ IPX Ordinary Shares (435,806 underlying)
435,806
Performance Rights (A$8)
[F5][F1]
Exercise: $8.00From: 2029-04-10Exp: 2030-04-10→ IPX Ordinary Shares (435,806 underlying)
435,806

Footnotes (7)

[F1]Ordinary Shares are traded on the Australian Stock Exchange (ASX).
[F2]318,666 vest in December 2026; 419,910 vest in April 2028.
[F3]American Depository Shares are traded on the Nasdaq.
[F4]One ADS is equivalent and exchangeable into ten ordinary shares.
[F5]Australian Dollars
[F6]Each performance right is convertible into one ordinary share after performance criteria have been met. Performance criteria are (1) four years of continuous service through 04/02/2030, and (2) IPX stock price on the ASX reaching a thirty-day volume-weighted average price (VWAP) of A$18.00.
[F7]Each option confers the right to purchase one ordinary share at the conversion price.

Signature

Samantha Birdsong Manning|2026-04-02

1 file